Gold-tier health policies set to rise by as much as 25pc next month
Some Australians with private health insurance will face premium increases of as much as 25 per cent from next month, according to new analysis from CHOICE.
Paige Cockburn is a multiplatform producer for the ABC's Specialist Reporting Team. She was previously ABC Science's health reporter. Prior to that, she was a digital reporter for the NSW news team in Sydney, where she covered politics and courts for some time. She started with the ABC in Brisbane on the national news desk.
Some Australians with private health insurance will face premium increases of as much as 25 per cent from next month, according to new analysis from CHOICE.
Australian researchers are hoping Artificial Intelligence will soon be making a huge difference in detecting breast cancer.
A new Australian artificial intelligence tool could transform breast cancer screening by offering a more personalised and accurate way to identify risk.
Transgender women will have their dignity "undermined" and could be made to feel "inferior" if a lesbian group is allowed to ban them from events, a court has heard.
A Victorian-based lesbian group is seeking an exemption to the Sex Discrimination Act so it can legally discriminate against transgender women when it holds public events.
The federal government is closely monitoring an outbreak of Nipah virus in India but has not received any advice to tighten border controls at this stage.
The tragic death of a young Melbourne woman who was stockpiling medication has prompted the federal health minister to move to change the way prescriptions are recorded.
Just months after US President Donald Trump warned women about taking paracetamol during pregnancy, a new study finds there is no evidence linking the painkiller to autism in children.
A major Australian study finds standard antidepressants aren't effective for around 20 per cent of people, who may need alternative treatments.
A major Australian study finds standard antidepressants are not effective for about 20 per cent of people, who may need alternative treatments.
Is it possible to make a "safe" AI therapy bot? We tested the limits of a new Australian-designed chatbot that's been carefully designed not to hallucinate or be your best friend.
A new report from Australia's peak doctors' body says private health insurance is increasingly failing to deliver value to the roughly 15 million Australians who hold a policy.
New data shows some patients with serious mental health conditions have been waiting more than 23 hours for a bed in emergency departments.
A new report recommends Australia’s public hospitals stop wasting money and adopt efficiency measures seen in other countries amid governmental tensions over a new funding deal.
Health ministers will meet next year and decide whether or not to make the system mandatory for all packaged food, something public health experts say is overdue.
The government is pouring billions into Medicare so you have a better chance of being bulk-billed but the decision to charge or not charge still rests completely with your doctor.
Topic:Explainer
An industry survey finds GPs are managing conditions typically handled by specialists due to high costs and only 12 per cent can afford to bulk-bill all patients.
Fertility treatments in NSW will be able to continue even in cases where the family donor limit has been breached after the state government issued a temporary exemption.
A total of 18 sunscreens have now been recalled or paused over inaccurate SPF protection claims, so we asked the experts what consumers should do now.
Topic:Explainer
The Therapeutic Goods Administration approves the drug Lecanemab, which can slow down cognitive decline in the early stages of Alzheimer's.
Donald Trump's advice that pregnant women should limit the use of paracetamol in pregnancy has been criticised as "baseless". So what does it mean for you?
Topic:Explainer
Patients have been left blindsided by Monash IVF's decision to temporarily halt treatments using donated eggs and sperm in New South Wales.
A national survey of Australians with rare cancers has found they face high costs and delayed, often inconsistent, care.
A national survey of Australians with rare cancers has found they face high costs and delayed, often inconsistent, care.
A new report paints a picture of a system that has failed to deliver fast and fair access to treatment for people with rare and less common cancers.